Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 1881-1893 |
| Journal | Neuropsychiatric Disease and Treatment |
| Volume | 13 |
| DOIs | |
| Publication status | Published - Jul 2017 |
Fingerprint
Cite this
}
Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions : A randomized controlled trial in the general hospital setting (CC-DIM). / Goorden, M.; van der Feltz-Cornelis, C.M.; van Steenbergen-weijenburg, K.M.; Horn, E.K.; Beekman, A.; Hakkaart-van Roijen, L.
In: Neuropsychiatric Disease and Treatment, Vol. 13, 07.2017, p. 1881-1893.Research output: Contribution to journal › Article › Scientific › peer-review
TY - JOUR
T1 - Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions
T2 - A randomized controlled trial in the general hospital setting (CC-DIM)
AU - Goorden, M.
AU - van der Feltz-Cornelis, C.M.
AU - van Steenbergen-weijenburg, K.M.
AU - Horn, E.K.
AU - Beekman, A.
AU - Hakkaart-van Roijen, L.
PY - 2017/7
Y1 - 2017/7
N2 - The study was undertaken to establish if collaborative care (CC) is a cost-effective treatment model when provided in the general hospital outpatient setting, rather than the primary care setting, for patients with chronic physical conditions, such as diabetes mellitus (DM), chronic heart failure (CHF), and chronic obstructive pulmonary disease (COPD), with comorbid major depressive disorder (MDD). The researchers performed a randomized controlled trial (RCT) evaluating CC provided by a consultant psychiatric nurse (CPN) as care manager; a consultation–liaison (CL) psychiatrist for diagnosis, supervision, and the prescription of antidepressant medication; and a medical specialist who provided treatment for the chronic physical condition. They found CC to be cost-effective with an incremental cost-effectiveness ratio (ICER) of €24,690 per quality-adjusted life year (QALY). Due to the high disease burden in this patient group, this may indicate that the CC model and setting may be preferable. However, the study was small, so replication in a larger study is warranted.
AB - The study was undertaken to establish if collaborative care (CC) is a cost-effective treatment model when provided in the general hospital outpatient setting, rather than the primary care setting, for patients with chronic physical conditions, such as diabetes mellitus (DM), chronic heart failure (CHF), and chronic obstructive pulmonary disease (COPD), with comorbid major depressive disorder (MDD). The researchers performed a randomized controlled trial (RCT) evaluating CC provided by a consultant psychiatric nurse (CPN) as care manager; a consultation–liaison (CL) psychiatrist for diagnosis, supervision, and the prescription of antidepressant medication; and a medical specialist who provided treatment for the chronic physical condition. They found CC to be cost-effective with an incremental cost-effectiveness ratio (ICER) of €24,690 per quality-adjusted life year (QALY). Due to the high disease burden in this patient group, this may indicate that the CC model and setting may be preferable. However, the study was small, so replication in a larger study is warranted.
U2 - 10.2147/NDT.S134008
DO - 10.2147/NDT.S134008
M3 - Article
VL - 13
SP - 1881
EP - 1893
JO - Neuropsychiatric Disease and Treatment
JF - Neuropsychiatric Disease and Treatment
SN - 1176-6328
ER -